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An open reading frame (ORF) with homology to interleukin-10 (IL-10) has been identified in rhesus cytomegalo-
virus (RhCMV). The IL-10-like protein is generated from a multispliced, polyadenylated early gene transcript
encompassing part of the corresponding UL111A ORF of human CMV (HCMV). Immunological analyses confirm
expression of the IL-10-like protein both in tissue culture and in RhCMV-infected rhesus macaques. Conserved ORFs
were subsequently identified in human, baboon, and African green monkey CMV, and a fully processed transcript
has been mapped in fibroblasts infected with the Towne strain of HCMV. The conservation of this previously
unrecognized ORF suggests that the protein may play an essential role in primate CMV persistence and patho-
genesis. © 2000 Academic Press
f
fINTRODUCTION
Cytomegaloviruses (CMV) are exceedingly adept at
persisting in healthy hosts, despite vigorous antiviral
immune responses. While antiviral immunity can contain
primary CMV infection and limit disease in most cases
(Alford and Britt, 1993), it is not sufficient to eliminate viral
reservoirs from the infected individual (Kondo et al., 1996;
So¨derberg-Naucle´r et al., 1997). Latent viral genomes
eriodically reactivate to produce infectious virus during
he life of an infected host, usually without clinical signs
f disease (Pass et al., 1982; McVoy and Adler, 1989). A
undamental issue for understanding mechanisms of vi-
al persistence is the identification and in vivo charac-
erization of CMV gene products that are involved in the
stablishment and maintenance of stable virus–host re-
ationships.
HCMV expresses multiple proteins that can potentially
ttenuate or subvert host immune responses in vivo.
hese include the US2, 3, 6, and 11 gene products that
re involved in downregulation of major histocompatibil-
ty complex type 1 (MHC I) expression in infected cells,
acilitating evasion from cytotoxic T-cell immune re-
ponses (reviewed in Wiertz et al., 1997). The UL18 ORF
ncodes an MHC I-like protein that may confer in vitro
esistance to natural killer (NK) cell lysis in cells express-
ng low amounts of surface MHC I (Reyburn et al., 1997).
CMV encodes both an a-chemokine (UL146) that likely
1 To whom correspondence and reprint requests should be ad-
ressed at the University of California, Center for Comparative Medi-
ine, Davis, CA 95616. Fax: (530) 752-7914. E-mail: kmloefler@
cdavis.edu.
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272unctions to modulate host neutrophil responses (Pen-
old et al., 1999), and a b-chemokine receptor (US28) that
binds and sequesters chemokines such as RANTES
(Neote et al., 1993; Gao and Murphy, 1994; Bodaghi et al.,
1998). The UL144 ORF expresses a protein that appears
to be a member of the tumor necrosis factor receptor
superfamily (Benedict et al., 1999), and the UL37 protein
functions as an inhibitor of apoptosis (Goldmacher et al.,
1999). Some of these genes (US2–11) have been dem-
onstrated to be dispensable for propagation in vitro (Kol-
lert-Jons et al., 1991; Greaves et al., 1995). However, it is
not known what roles these proteins play during virolog-
ical expression of HCMV persistence and pathogenesis
in vivo.
We recently reported on the development of a nonhu-
man primate model of CMV that has been used to study
viral and host determinants of persistence and patho-
genesis (Tarantal et al., 1998; Lockridge et al., 1999). We
have used this model to identify a novel ORF in RhCMV
with sequence homology to cellular IL-10 (cIL-10). cIL-10,
also referred to as cytokine synthesis inhibitory factor, is
a complex and multifunctional cytokine that downregu-
lates inflammatory responses and modulates MHC I and
II surface expression in multiple immune cell types (re-
viewed in Moore et al., 1993). Based on the strong co-
linearity of the primate CMV genomes, we identified the
cognate, previously unrecognized ORF in HCMV and in
baboon and African green monkey CMV (BaCMV,
AGMCMV, respectively). This is the first report of primate
CMV encoding and transcribing an IL-10-like gene prod-
uct. The identification of this previously unrecognized
gene has important ramifications for resolving mecha-
nisms of CMV immune evasion.
IC
a
1
d
H
5
s
e
O
w
t
m
t
t
c
w
R
m
t
t
s
t
s
t
c
t
w
D
f
t
l
s
2
a
q
w
n
I
H
h
t
p
e
M
T
d
T
s
g
t
b
n
s
a
m
n
c
n
e
R
c
q
S
f
t
c
s
w
a
O
t
i
t
w
t
s
e
h
P
f
c
273PRIMATE CMV IL-10-LIKE PROTEINRESULTS
solation of RhCMV IL-10 sequence
Random restriction endonuclease fragments of Rh-
MV were cloned, sequenced at the termini, translated,
nd aligned with predicted ORF of HCMV (Chee et al.,
990). Analysis of a partial library of the RhCMV genome
emonstrated that RhCMV is essentially colinear with
CMV (data not shown). One clone was isolated with a
9 end that aligned with HCMV UL105 (helicase; acces-
ion number AF079496), but with a 39 terminus that
xhibited no apparent homology to any identified HCMV
RF. A BLAST search of protein sequences in GenBank
ith the predicted translation products of the 39 end of
he RhCMV clone revealed significant homology to mam-
alian cIL-10 sequences (not shown). The 39 terminus of
he clone was predicted to be near the short, uncharac-
erized UL110/111 ORF of HCMV, based on the size of the
loned RhCMV fragment and the alignment of the 59 end
ithin UL105.
NA analysis of RhCMV IL-10 expression
59 and 39 RACE reactions were performed to deter-
ine whether this region of the RhCMV genome was
ranscribed. Amplification products from the RACE reac-
ions were cloned, sequenced, and compared to the
equence of the genomic clone. Sequences of partial
ranscripts revealed that the 59 and 39 ends of the tran-
cript were generated by multiple splice events and that
he transcript was polyadenylated. PCR products of
DNA, using primers determined from the termini of
ranscripts and primers used for the RACE reactions,
ere shorter than the amplicons obtained using genomic
NA as a template (Fig. 1, lanes 1–4). Similarly, the
FIG. 1. PCR analysis of RhCMV and HCMV IL-10-like genes. RNA
rom RhCMV- or HCMV-infected fibroblasts was used to synthesize
DNA, either the 59 or 39 end of the transcript (59 and 39 RACE,
respectively; lanes 2 and 4 for RhCMV, 9 and 11 for HCMV) or full-length
mRNA (RhCMV: lane 6; HCMV: lane 13). PCR amplification of the cDNA
is presented in comparison to amplification of genomic DNA (RhCMV:
lanes 1, 3, and 5; HCMV: lanes 8, 10, and 12). In all cases, cDNA sizes
are less than corresponding amplification of genomic DNA. M: fx174/
HaeIII DNA marker.ull-length transcript was also significantly shorter than
he corresponding unspliced genomic sequence (Fig. 1,
u
Ianes 5 and 6). The 746-nucleotide (nt) transcript (acces-
ion number AF200417) consisted of four exons, 275,
22, 62, and 187 nt in length. The three introns (95, 427,
nd 84 nt) all contained consensus splice-site se-
uences (59 GT. . .AG 39), and the site of polyadenylation
as 17 bases downstream from a consensus polyade-
ylation signal (AATAAA).
solation of HCMV IL-10 cDNA
A more detailed examination of UL110/111 region of
CMV was undertaken, since the RhCMV clone would
ave represented the first example of noncolinearity be-
ween the RhCMV and HCMV genomes. A series of
rimers (Table 1) was designed to amplify the 59 and 39
nds of potential transcripts using RNA obtained from
RC-5 cells infected with the Towne strain of HCMV.
wo primers, located downstream of the UL111A ORF,
etected a multiply spliced, polyadenylated transcript.
he amplicons of both 59 and 39 RACE cDNAs were
horter in length than the corresponding amplification of
enomic HCMV DNA (Fig. 1, lanes 8–11). The amplifica-
ion product of the full-length transcript (accession num-
er AF202536), based on the mRNA start and polyade-
ylation sites identified by the RACE reactions, was also
horter in length than the corresponding genomic DNA
mplicon (Fig. 1, lanes 12 and 13). A fully processed
essage (633 nt) initiated at position 159,642 and termi-
ated at position 160,430, 14 bases downstream from a
onsensus polyadenylation sequence (AD169 coordi-
ates, X17403). The transcript was generated from three
xons/two introns, versus four exons/three introns in
hCMV. The cDNA for RhCMV and HCMV IL-10 exhibited
onsiderable sequence divergence with only 45% se-
uence identity (not shown).
equence comparisons of predicted open reading
rames
Both the RhCMV and HCMV transcripts encoded ex-
ended translation products beginning at methionine
odons located 77 and 38 bases, respectively, down-
tream of the transcription start sites. The RhCMV ORF
as 189 amino acids (aa), and the HCMV ORF was 176
a. The amino-terminal portion of the HCMV IL-10-like
RF corresponded to the UL111A ORF; splicing of the
ranscript maintained an open reading frame prior to the
dentified stop codon of UL111A. Both proteins appeared
o include signal peptides (Nielsen et al., 1997) that
ould yield cleaved peptides of 158 and 151 aa, respec-
ively. It is not known whether the CMV IL-10 proteins are
ecreted, although cIL-10 is a secreted protein (MacNeil
t al., 1990). The lengths of the cleaved cellular IL-10 in
umans and rhesus macaques (accession numbers
22301 and P51496, respectively) are both 160 aa (178 aa
ncleaved). Pairwise sequence comparisons of the viral
L-10 proteins and their apparent cellular homologs indi-
200417
274 LOCKRIDGE ET AL.cated that the viral ORF were nearly as divergent from
each other as they were from their hosts. Mammalian
IL-10 proteins are strongly conserved; the human and
macaque proteins are 95% identical (ID) and 96% similar
(SI) (Table 2; protein comparisons are for cleaved pro-
teins only). Both the RhCMV and HCMV proteins were
25% ID/41% SI with their respective host cIL-10. The two
viral ORF were 31% ID/38% SI. There was almost no
sequence variation between different isolates of either
RhCMV or HCMV. There was only one amino acid differ-
ence between RhCMV strain 68-1 and a primary isolate
(accession number AF200740); the Towne strain of
HCMV and the predicted protein of AD169 were identical,
except for one additional amino acid in the Towne se-
quence.
Characterization of IL-10 in AGMCMV and BaCMV
To determine whether other primate CMV encoded a
similar ORF, primers 316/312 (Table 1) were used to
T
Primers Used for PC
Primer Sequence (59 3
295 ATGACAGACTGTGACTCCTC
307 CGTGACCAATGAACTCATGG
310 ATGGAGCACGTCATTG
312 GTGGTTAAACAGTACGTTTAT
316 GCAGTAGATACCAGATTCT
328 ATCCGAGAATTCTAAACCGG
329 ATGGCGGTGGTCGTGCTTTC
344 GAACTGCAGCAGGAACGb
376 TAGCCTGGAGAAGGATCCGA
378 GGACTCAAGACGGAATTGCA
381 TTGTAGATGGATTCTAGCGTC
386 ATGCTGCGGCGATGCTGTCG
393 ATTCTCTGTTGCAGCGGCGG
a The Accession Nos. for the RhCMV and HCMV sequences are AF
b Underlined and bold nucleotides are explained in the text.
T
Percentage Identity/Similarity
Mmu cIL-10a RhCMV HCM
Human cIL-10d 95/96 25/41 27/37
Mmu cIL-10 25/41 27/37
RhCMV 31/38
HCMV
AGMCMV
BaCMV
EBV
a Accession No. P51496.
b Accession No. P03180.
c Mature protein.
d Accession No. P22301.amplify the corresponding regions of the BaCMV and
AGMCMV genomes (accession numbers AF202535 and
AF202534, respectively). Using the protein sequence of
the RhCMV and HCMV proteins, putative cleaved pro-
teins of 159 aa each were identified in both species of
African nonhuman primate CMV. The proteins would be
generated from a primary transcript consisting of four
exons/three introns. For both transcripts, introns and
polyadenylation would include consensus sequences.
Alignment of these two CMV with RhCMV and HCMV
IL-10-like ORF demonstrated strong sequence conserva-
tion among the simian CMV. The RhCMV, BaCMV, and
AGMCMV were 67–79% ID/72–82% SI compared to each
other. Both BaCMV and AGMCMV IL-10-like ORF were
comparably divergent from cIL-10 and the HCMV ORF,
similar to RhCMV. Other herpesviruses have transduced
cIL-10 sequences, including Epstein–Barr virus (EBV)
(Hsu et al., 1990). The EBV IL-10 is strongly conserved
with cIL-10 sequences, although EBV IL-10 does exhibit
E, and RT Reactions
Positiona
RhCMV: 1,426–1,406
RhCMV: 1,539–1,558
RhCMV: 1,513–1,495
b RhCMV: 2,441–2,415
HCMV: 160,432–160,407
RhCMV: 727–745
HCMV: 159,225–159,243
RhCMV: 2,398–2,377
RhCMV: 1,230–1,251
RhCMV: 2338–2322
ACb RhCMV: 1125–1151
TGC HCMV: 160,066–160,093
HCMV: 160,118–160,094
GGTCTCTT HCMV: 159,667–159,699
RhCMV: 1,091–1,111
and X17403, respectively.
lular and Viral IL-10 Proteins
AGMCMV BaCMV EBV9 b Length (aa)c
28/39 27/37 90/92 160
28/40 27/39 86/90 160
73/77 67/72 25/40 158
33/40 32/41 29/41 151
79/82 31/42 159
30/41 159
147ABLE 1
R, RAC
39)
TAGAG
AGb
AG
GAACG
TAGTA
GAGC
GTGAT
TABLE 2
of Cel
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275PRIMATE CMV IL-10-LIKE PROTEINfunctional differences from the cIL-10 protein (Liu et al.,
1997).
Search for IL-10 in other b-herpesviruses
Sequence alignments of the cIL-10 with the CMV IL-
10-like ORF revealed there were 20 amino acids con-
served in all isolates, including four cysteine residues
(the signal peptide was not included) (Fig. 2A). These
amino acids were also conserved in EBV IL-10 (not
shown). There were an additional 15 amino acids con-
served in all four CMV representatives. Despite the se-
quence divergence of the CMV IL-10-like proteins from
cIL-10, hydropathic profiles of the proteins were similar
(Fig. 2B). These data imply conservation of structure.
Computer searches were performed on the three trans-
lation reading frames between UL105 and 112 of murine
CMV (MCMV) and human herpesvirus 6 (HHV6), using
conserved amino acid motifs in the cellular and viral
IL-10 proteins. No homologous proteins were identified,
although it should be noted that these other b-herpesvi-
uses have regions between UL105 and 112 without
dentified ORF. Based on splicing of the IL-10-like ORF of
rimate CMV, detailed RNA analysis is warranted for this
rea of the genome of MMV and HHV6, to rule out the
xistence of homologous proteins.
ntron–exon structure
The protein alignments, together with mapping of the
ranscripts, are informative about the evolutionary relat-
dness of these ORF. Two exon–exon splice junctions
ave been conserved in the cellular and CMV IL-10 (Fig.
A). These correspond to the junctions between exons 1
nd 2, and between exons 3 and 4 of cIL-10. The protein
lignments suggest that primate CMV have lost the in-
ron between exons 2 and 3 of cIL-10, resulting in an
n-frame fusion of these exons (Fig. 2C). The HCMV ORF
as also lost the intron between exons 4 and 5 of cIL-10,
esulting in a gene composed of three exons/two introns.
hese data are consistent with transduction of a cIL-10
ene by a progenitor CMV with sequence variation and
rogressive loss of introns during speciation.
xpression kinetics
The expression kinetics of the RhCMV IL-10-like gene
ere determined by Northern blot analysis following
nfection of primary rhesus skin fibroblasts (Fig. 3). An
ntisense RNA probe to exons 3 and 4 of the RhCMV
RF hybridized with an approximately 0.9-kilobase (kb)
ranscript beginning at 12 h postinfection. The transcript
as not detected in the presence of the protein synthe-
is inhibitor cycloheximide but was detected in the pres-
nce of the replication inhibitor phosphonoformic acid
PFA). Since the concentration of PFA used for the infec-
ion had been previously demonstrated to inhibit RhCMV
eplication (data not shown), the expression of the 0.9-kb IL-10 transcript was consistent with that of an early gene.
he antisense IL-10 probe also detected an uncharac-
erized transcript of approximately 2.6 kb. The absence of
xpression of the uncharacterized 2.6-kb transcript in the
resence of PFA indicated that this was a late transcript.
estern blot analysis of timed RhCMV-infected cell ly-
ates probed with polyclonal rabbit antisera confirmed
he early gene kinetics of the RhCMV IL-10-like protein
data not shown). RT/PCR analysis of RNA from cells
nfected with HCMV demonstrated the presence of the
L-10 transcript by 12 h postinfection (data not shown).
orthern blot analysis was not performed for HCMV.
mmunogenicity and expression of IL-10 in
hCMV-infected macaques
We next determined whether sera from a rhesus ma-
aque, chronically infected with RhCMV, would recog-
ize the viral IL-10-like protein. Cos-7 cells were trans-
ected with a myc-epitope-tagged expression vector
cDNA m/H IL-10 containing the genomic sequence of
he RhCMV IL-10-like gene. Figure 4A (lanes 1–5) shows
n immunoblot of the transfected Cos-7 cell lysate
robed with either polyclonal rabbit antisera or sera from
chronically RhCMV-infected rhesus macaque. Both the
abbit and monkey postimmune sera recognized the
ame 28-kDa IL-10 fusion protein recognized by the anti-
yc antibody. This protein was not detected with preim-
une sera. These results demonstrated IL-10-like pro-
ein expression during RhCMV infection. We subse-
uently examined the kinetics of the humoral immune
esponse against the IL-10-like protein during RhCMV
nfection. Figure 4A (lanes 6–9) also shows Western blot
nalyses of RhCMV-infected cell lysates probed with
equential plasma from a rhesus macaque infected with
hCMV (Lockridge et al., 1999). Beginning at 2 weeks
ostinoculation, an IgG antibody response against an
pproximately 25-kDa protein was detected; this re-
ponse continued with increasing reactivity at 6 months
ostinoculation. Preimmune plasma did not exhibit reac-
ivity to this protein. Rabbit polyclonal anti-IL-10 sera
ecognized a protein of identical size (data not shown).
hese results indicate that the IL-10-like protein was
xpressed during RhCMV infection and was recognized
y the host immune response. Further evidence of in vivo
xpression was shown by immunohistochemical analy-
is of thymic tissue from a rhesus macaque coinfected
ith RhCMV and simian immunodeficiency virus (Fig.
B). Cells with intranuclear and cytoplasmic inclusions
ere stained with a rabbit polyclonal antisera generated
gainst bacterially synthesized RhCMV IL-10-like protein;
taining was confined to the cytoplasm.
DISCUSSIONThis report describes the first characterization of an
L-10-like gene within b-herpesviruses and highlights the
n of ov
sus ma
276 LOCKRIDGE ET AL.utility of the rhesus macaque model of CMV to facilitate
FIG. 2. Protein alignments of the primate CMV IL-10-like proteins wit
vIL-10-like protein. Identical amino acids in all three proteins are boxed,
exon–exon junctions in each protein are noted by a vertical line. The regio
plot comparisons of cellular and viral IL-10 proteins for human (left) or rhe
are depicted as boxes.new knowledge of HCMV. A fortuitous subclone of the
RhCMV genome with homology to cIL-10 spurred thereexamination of the corresponding region of HCMV to
. (A) Amino acid comparison of human cIL-10 and HCMV and RhCMV
CMV IL-10 are shaded. The five exons of the cIL-10 are indicated. The
erlap of HCMV IL-10-like protein with UL111A is noted. (B) Hydrophobicity
caque (right). (C) Splicing patterns of cellular and viral IL-10 genes. Exonsh cIL-10
or in thedetect a previously unrecognized gene within HCMV.
The Il-10-like ORF adds to the growing list of identified
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277PRIMATE CMV IL-10-LIKE PROTEINORF within HCMV with the potential to modulate host
antiviral immune responses (see Introduction).
IL-10 homologs have been reported for other herpes-
viruses, including Epstein–Barr virus (EBV) (Hsu et al.,
1990; Moore et al., 1990) and equine herpesvirus 2 (Rode
et al., 1993; Fleming et al., 1997). The EBV IL-10 homolog
is highly conserved in sequence with its cellular coun-
terpart (Vieira et al., 1991) (Table 2), yet has evolved
biological functions distinct from cIL-10 (discussed later).
Gesser et al. (1997) found that biological functions of
cIL-10 are confined to small, defined segments of the
protein. Functional domains for human cIL-10 have been
localized to a 9-aa sequence at the carboxyl end and an
8-aa sequence near the amino terminus of the pro-
cessed protein. The amino proximal motif that exhibits
regulation of MHC II antigen expression and induces
proliferation of murine mast cells has only two conserved
amino acids with corresponding sequence in EBV IL-10.
The carboxyl-terminal motif, which determines the cyto-
kine synthesis inhibitory activity and affects cellular mi-
gration, is only partially conserved in EBV (6 of 9 amino
acids). There is minimal sequence homology in these
motifs between cIL-10 and CMV IL-10. Given the diver-
gence of the EBV IL-10 from cIL-10 in these two func-
tional regions, divergence of primate CMV IL-10 from
cIL-10 was not unexpected.
The function of the IL-10-like ORF is under investiga-
tion. Cellular IL-10 is a multifunctional cytokine that has
suppressive effects on inflammation and cytokine pro-
duction (Fiorentino et al., 1989). EBV IL-10 inhibits syn-
hesis of cytokines by activated T cells, inhibits antigen-
pecific T-cell proliferation and induces proliferation and
g secretion in activated B cells (Rousset et al., 1992; de
aal Malefyt et al., 1997). It is well documented that
nfection with CMV can have immunosuppressive effects
n vitro (Einhorn and Ost, 1984; Schrier and Oldstone,
986; Schrier et al., 1986). Acquisition of an IL-10-like
ene may allow CMV to subvert the antiviral cell-medi-
FIG. 3. Northern blot analysis of RhCMV-infected primary rhesus
macaque skin fibroblasts. Primary rhesus skin fibroblasts were in-
fected with RhCMV and RNA was harvested at different times postin-
fection (Time PI). Cells were infected in the presence (1) or absence
(2) of either cycloheximide (CHX) or phosphonoformic acid (PFA). RNA
was analyzed by Northern blot, using an antisense RNA probe to exons
3 and 4 of RhCMV IL-10. The approximate 0.9-kb IL-10 gene and an
unidentified 2.6-kb transcript hybridizing to the probe are indicated.ted immune response long enough to establish a latent
nfection. Our data indicate that the RhCMV IL-10-likeene is produced during infection of rhesus macaques
nd is a target of the humoral immune response.
Identification of this gene in primate CMV suggests
hat acquisition of cIL-10 function may be important for
he establishment and maintenance of viral persistence.
ndeed, phenotypic data of CMV infection are compatible
ith possible functions of a viral IL-10-like protein, based
n known functions of cIL-10. cIL-10 has been shown to
ecrease antigen-specific CD41 T-cell proliferation by
educing the expression of MHC II molecules on antigen-
resenting cells (de Waal Malefyt et al., 1997). Acquisi-
tion of this cIL-10 function may allow viral escape from
cell-mediated immune surveillance, since CD41 T cells
are required for CD81 T-cell responses. Such a mecha-
nism may play a role in the early stages of CMV infection
prior to the development of host antiviral immune re-
sponses that protect the infected host from disease
(Lockridge et al., 1999). According to this scenario, any
virally induced attenuation of inflammatory responses
FIG. 4. Protein analysis of RhCMV-infected cells. (A) Western blot
analysis of Cos 7 (lanes 1–5) or primary rhesus macaque skin fibroblast
cell lysates (lanes 6–9). Cos 7 cells were transfected with pcDNA m/H
IL-10 and probed with anti-myc antibody (lane 1), pre- and postimmune
polyclonal rabbit sera (diluted 1:50; lanes 2 and 3), and pre- and
postimmune RhCMV-infected rhesus macaque plasma (diluted 1:100;
lanes 4 and 5). RhCMV infected skin fibroblasts were probed with
longitudinal plasma from a RhCMV-infected rhesus macaque (diluted
1:50), preinoculation (lane 6) or 2 weeks (lane 7), 3 months (lane 8), and
6 months (lane 9) postinoculation. (B) Immunohistochemical analysis of
RhCMV vIL-10-expressing cells. Thymic tissue from a rhesus macaque
coinfected with RhCMV and SIV. vIL-10-positive cells are brown (DAB)
and cells are counterstained with hematoxylin (blue). Examples of
positively stained cells exhibiting RhCMV cytopathic effect are noted by
arrows.
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278 LOCKRIDGE ET AL.would provide the virus with a slight replicative advan-
tage to disseminate from the primary site of infection to
sites of persistence and latency.
Recently, HCMV was shown to inhibit interferon-g
(IFN-g)-induced MHC II expression on infected cells by
oth disruption of the JAK/STAT signaling pathway (Miller
t al., 1998) and repression of class II transactivator
CIITA) mRNA expression (LeRoy et al., 1999). Interest-
ngly, cIL-10 has been shown to inhibit expression of
FN-g-induced tyrosine phosphorylation of STAT1 (Ito et
l., 1999) and IFN-g-induced expression of CIITA mRNA
O’Keefe et al., 1999), thus supporting the presence of an
CMV protein with IL-10-like functionality. Additional
tudies regarding the functional properties of the CMV
L-10-like protein are ongoing in our laboratory and will
e necessary to determine the role of the IL-10-like
rotein in the immunopathogenesis of CMV infection.
MATERIALS AND METHODS
Virus strains, constructs, and cells. The 68-1 strain of
hCMV (Asher et al., 1974) (American Type Culture Col-
ection [ATCC], Manassas, VA) and Towne strain of
CMV were used for these studies (generously provided
y R. Spaete). Primary rhesus skin fibroblasts were used
or RhCMV infections (Kaur et al., 1996). HCMV was
ropagated on MRC-5 human diploid fibroblasts (ATCC).
os-7 cells were transfected with a myc/His epitope-
agged expression vector (pcDNA3.1 myc/His; Invitrogen,
arlsbad, CA) containing the genomic sequence of the
hCMV IL-10-like gene (pcDNA m/H IL-10). Cells were
ransfected with DOTAP/DOPE (Avanti Polar-Lipids, Inc.,
labaster, AL). The genomic sequence was amplified
ith primers 376 and 344 and cloned into pcDNA3.1myc/
is, using BamHI and PstI restriction endonuclease sites
within 376 and 344, respectively (Table 1; restriction sites
are underlined). This construction inserted the RhCMV
IL-10 genomic sequence, beginning 30 nucleotides up-
stream of the translation start site and extending to a
point four nucleotides upstream of the translation stop
codon, in-frame with the 39 epitope tags. The BamHI
restriction site within 376 was generated by modifying
two nucleotides within the 59 untranslated portion of the
sequence (GA 3 TC) (Table 1; modified bases are in
bold). In addition, the use of the PstI restriction site within
344 eliminated the carboxyl-terminal amino acid (phenyl-
alanine) from the fusion protein.
PCR and RACE reactions. Conditions for RNA isola-
tion, PCR, reverse-transcription, and 59/39 RACE reac-
tions have been described previously (Barry et al., 1996).
The following primers were used for PCR, RACE, and
reverse-transcription reactions (see Table 1 for primer
sequences). Primers 316 and 312 were used to amplify
genomic fragments spanning the IL-10 region from
HCMV (Towne), AGMCMV, BaCMV, and a primary isolate
of RhCMV. It should be noted that there is one base pairdifference between the sequence of 312 and HCMV; the
“G” residue, three nucleotides from the 39 end of PAB312
(Table 1, bold), corresponds to “A” in HCMV. Primers 307
and 378 were used for 39 RACE reactions for RhCMV and
HCMV, respectively; RT reactions were primed with the
39 adaptor primers of Frohman et al. (1988). Primers 310
and 312 were used to prime the RT reaction for 59 RACE
for RhCMV and HCMV, respectively. The RhCMV 59 RACE
cDNA were amplified using primer 295 and the 59 adap-
tor primer of Frohman et al. (1988). The HCMV 59 cDNA
was amplified using primer 381 and the SMART RACE
cDNA amplification kit from Clonetech (Palo Alto, CA).
Full-length cDNA for RhCMV and HCMV were generated
using primer pairs 393/312 and 386/312, respectively.
PCR amplification products were cloned into the
TOPO-TA vector (Invitrogen) for sequencing.
Sequence analysis. Sequencing was performed by
Davis Sequencing (Davis, CA). Sequence comparisons
and hydrophobicity plots were performed with the SE-
QWeb sequence analysis software (Genetics Computer
Group, Madison, WI). BLAST sequence searches were
performed using the resources at the National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov).
Polyclonal rabbit antisera. The RhCMV IL-10 cDNA
was amplified with primers 329 and 328 and cloned into
the pGEX2T vector (Pharmacia Biotech, Piscataway, NJ).
Primer 329 also included a BamHI restriction site at the
59 end of the primer and 328 was modified by one base
to incorporate an EcoRI restriction site to facilitate clon-
ing into the expression vector (Table 1, G3 C, italicized).
This construction placed the IL-10 gene in-frame with the
GST fusion protein beginning 23 amino acids down-
stream of the IL-10 translation start codon. IL-10/GST
fusion protein was generated and purified according to
the manufacturer’s directions. Antisera were generated
by immunization of rabbits with RhCMV IL-10/GST fusion
protein at Animal Resource Services, University of Cali-
fornia, Davis.
RNA and protein analysis. Northern analysis was per-
formed according to published protocols (Kravitz et al.,
1997). Rhesus skin fibroblasts were infected with RhCMV
strain 68-1 at an m.o.i. of 1. RNA was purified at 12, 24, 48,
and 72 h postinfection and analyzed by Northern blot,
using an antisense RNA probe corresponding to exons 3
and 4. Infections were performed in the presence and
absence of cycloheximide (200 mg/ml, 12 h only) or
hosphonoformic acid (400 mg/ml, 24, 48, 72 h). Immu-
oblotting and immunohistochemistry were performed
s previously described (Lockridge et al., 1999).
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